Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29,881,634
-
Total 13F shares
-
7,725,381
-
Share change
-
-746,828
-
Total reported value
-
$71,697,431
-
Put/Call ratio
-
5.9%
-
Price per share
-
$9.29
-
Number of holders
-
31
-
Value change
-
-$6,964,813
-
Number of buys
-
9
-
Number of sells
-
15
Institutional Holders of Profound Medical Corp. - Common Shares (PROF) as of Q1 2023
As of 31 Mar 2023,
Profound Medical Corp. - Common Shares (PROF) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,725,381 shares.
The largest 10 holders included
GAGNON SECURITIES LLC, FIL Ltd, LETKO, BROSSEAU & ASSOCIATES INC, Timelo Investment Management Inc., Gagnon Advisors, LLC, ROYCE & ASSOCIATES LP, Raymond James Financial Services Advisors, Inc., Royal Bank of Canada, Zweig-DiMenna Associates LLC, and BANK OF AMERICA CORP /DE/.
This page lists
30
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.